168 related articles for article (PubMed ID: 14567021)
21. Surgical management of advanced gastric cancer: An evolving issue.
Marano L; Polom K; Patriti A; Roviello G; Falco G; Stracqualursi A; De Luca R; Petrioli R; Martinotti M; Generali D; Marrelli D; Di Martino N; Roviello F
Eur J Surg Oncol; 2016 Jan; 42(1):18-27. PubMed ID: 26632080
[TBL] [Abstract][Full Text] [Related]
22. Short-term curative effect of S-1 plus oxaliplatin as perioperative chemotherapy for locally advanced gastric cancer: a prospective comparison study.
Zhao Q; Li Y; Huang J; Fan L; Tan B; Tian Y; Yang P; Jiao Z; Zhao X; Zhang Z; Wang D; Liu Y
Pharmazie; 2017 Apr; 72(4):236-240. PubMed ID: 29441995
[TBL] [Abstract][Full Text] [Related]
23. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer.
Cheong JH; Shen JY; Song CS; Hyung WJ; Shen JG; Choi SH; Noh SH
Ann Surg Oncol; 2007 Jan; 14(1):61-8. PubMed ID: 17058123
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant treatment of gastric cancer with peritoneal dissemination.
Yonemura Y; Bandou E; Sawa T; Yoshimitsu Y; Endou Y; Sasaki T; Sugarbaker PH
Eur J Surg Oncol; 2006 Aug; 32(6):661-5. PubMed ID: 16621433
[TBL] [Abstract][Full Text] [Related]
25. [Influence of intraperitoneal chemotherapy to a recurrence pattern of gastric cancer with serosal exposure].
Maruyama M; Nagahama Y; Sato E; Maruyama S; Sanada T; Koide A; Ohhinata R; Shima Y; Ebuchi M
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1946-8. PubMed ID: 18219860
[TBL] [Abstract][Full Text] [Related]
26. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
27. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
[TBL] [Abstract][Full Text] [Related]
28. Advances in the treatment of gastric cancer: 2019.
Ilson DH
Curr Opin Gastroenterol; 2019 Nov; 35(6):551-554. PubMed ID: 31436556
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer].
Wei G; Fang GE; Bi JW; Shen XJ; Nie MM; Xue XC; Hua JD
Ai Zheng; 2005 Apr; 24(4):478-82. PubMed ID: 15820074
[TBL] [Abstract][Full Text] [Related]
30. A systematic overview of chemotherapy effects in gastric cancer.
Janunger KG; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):309-26. PubMed ID: 11441938
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
32. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
34. Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer.
de Bree E; Witkamp AJ; Zoetmulder FA
Eur J Surg Oncol; 2000 Sep; 26(6):630-2. PubMed ID: 11034822
[No Abstract] [Full Text] [Related]
35. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.
Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Miyata H; Monden M
J Surg Oncol; 2004 Oct; 88(1):39-43. PubMed ID: 15384086
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
[TBL] [Abstract][Full Text] [Related]
37. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
[TBL] [Abstract][Full Text] [Related]
38. [Perioperative chemotherapy in gastric cancer treatment - the surgeons view].
Hoskovec D
Cas Lek Cesk; 2014; 153(5):227-30. PubMed ID: 25370767
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy for advanced gastric cancer.
Al-Batran SE; Jäger E; Scholz M
J Clin Oncol; 2007 Feb; 25(6):729; author reply 730. PubMed ID: 17308279
[No Abstract] [Full Text] [Related]
40. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report.
Crookes P; Leichman CG; Leichman L; Tan M; Laine L; Stain S; Baranda J; Casagrande Y; Groshen S; Silberman H
Cancer; 1997 May; 79(9):1767-75. PubMed ID: 9128994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
